Alcon AG | ALC - Ebitda

Stock Price
59.30
Daily Change
-0.58 -0.97%
Monthly
-0.37%
Yearly
-24.48%
Q2 Forecast
58.14

Alcon AG reported $317M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
AstraZeneca USD 5.23B 272M Sep/2025
Bayer EUR 1.97B 457M Dec/2025
Essilor EUR 3.09B 356M Dec/2024
Fresenius EUR 850M 22M Sep/2025
Fresenius Medical Care EUR 1.07B 142.74M Dec/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
GRIFOLS EUR 347.24M 58.35M Jun/2025
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.44B 263M Dec/2025
Novartis USD 4.77B 1.11B Dec/2025
Philips EUR 738M 9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 3.31B 3.65B Mar/2026
Smith & Nephew USD 796M 139M Dec/2025
UCB EUR 1.6B 570M Dec/2025